Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

PURPOSE: Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall survival. Insulin resistance is defined as a pathological condit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Surg Oncol
Main Authors: Alan, Ozkan, Akin Telli, Tugba, Aktas, Bilge, Koca, Sinan, Ökten, Ilker Nihat, Hasanov, Rahib, Basoglu, Tugba, Arikan, Rukiye, Demircan, Nazim Can, Ercelep, Ozlem, Kaya, Serap, Ugurlu, Mustafa Umit, Kaya, Handan, Akgul Babacan, Nalan, Dane, Faysal, Yumuk, Perran Fulden
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488234/
https://ncbi.nlm.nih.gov/pubmed/32907593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-02019-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares